Introduction
Although the therapeutie efTect of neuroleptie medication has been attributed largely to dopamine receptor blockade, noradrenergic transmission is also inhibited by administration of these drugs and should not be overlooked. In recent years extensive studies of the central noradrenergie metabolism led to the hypothesis of noradrenergie dysfunction in schizophrenia. Both norepinephrine and its metabolite MHPG have been found to be increased in the nucleus accumbens, mesencephalon, and Iimbie regions of the brain of paranoid schizophrenics (Farley et aI. 1978 ).
In addition, investigations of noradrenergie receptor function have been conducted. Alpha-adrenergic receptors are found in hypothalamie, Iimbie, and cortical structures, whereas beta-receptors are found in cortical projections from the locus coeruleus. Although beta-adrenoceptor function has not yet been examined, alpha-adrenoceptor function on platelets, as a model for alpha-adrenergie function throughhout the body, has been studied in schizophrenie patients. Elevated alphaadrenoceptor numbers have been found in these patients associated with a deficiency of prostaglandine E t-stimulated cyclie AMP production, a function known to be inhibited byalpha-receptor stimulation (Kafka and van Kammen 1983) . It is not known, however, whether these peripheral findings parallel brain metabolism. Pharmacological receptor manipulation has been another approach to investigate noradrenergie mechansisms, although neuroendocrine responses to pharmacological challenges have not been elucidated in detail (Matusseket aI. 1980) . Therefore, we compared endocrine responses ofthe hypothalamie-pituitary-adrenal and -somatotropic axes following clonidine (CLON), a predominantly centrally acting alphaNeceptor agonist, in patients with acute paranoid schizophrenia and healthy subjects, in order to explore alpha-adrenoceptor function in schizophrenia.
Methods
Nine patients, live women and four men, with acute paranoid-type schizophrenie psyehosis, were evaluated on the basis of a dinical interview using ICD-9 (295.3) and . Their mean age was 34.2 ± 3.7 yeras; two women were tested during the midproliferal phase and two du ring the midluteal phase of the menstrual cyde, one was postmenopausal. The study was perfonned after a drugfree period ofat least 3 days. The Brief Psychiatrie Rating Scale (BPRS) and the Clinical Global Impression (CGI) scale were completed for eaeh patient one day prior to the CLON test. Mean BPRS score was 38.2 ± 3.6 and mean CGI scale score was 5.7 ± 0.3. Nine nonnal subjeets triple-matehed for age (37.9 ± 4.9 years), gender (5 women, 4 men) and ovarian status (2 women were in the midproliferal phase and 2 in the mdluteal phase of the eyde, I was postmenopausal), also were studied. The CLON stimulation test was condueted on all subjects at rest in bed at 8:()() a. m. after an overnight fast. One hour after the insertion ofan intravenous line in an anteeubital vein, 2ltg/kg CLON, diluted in 10 ml saline (0.9%), ws injeeted slowly over 10 min. For measurement of plasma GH, ACTH, and cortisol, blood was colleeted at-15, 0,15,30, 45,60,90 and 120 min. Plasma GH and cortisol analyses employed standard RIA teehniques. Plasma ACTH was measured by RIA after extraetion using N-tenninal speeilie antibodies.
The results are expressed as the mean ± SE. The GH, ACTH, and cortisol responses following CLON of patients and nonnal controls were calculated as the net and total area under the response eurve (AUC), using trapezoidal integration. The data were analyzed using nonparametric statistical method: group eomparison by the Mann-Whitney U test; eorrelations by the Speannan's rank order eorrelation (rs). All significance levels are two-tailed.
Results

GH
Compared with healthy subjects, the schizophrenie patients exhibited a significantly attenuated GH response to CLON (436 ± 267 vs. 59 ± 44 ng· min/ml; U = 14, P < 0,05) associated with normal basal plasma GH concentrations (Figs. la and  2a) .
ACTH
Although the total amount of ACTH secreted during CLON stimulation was significantly higher in schizophrenie patients (3313 ± 516 vs. 2013 ± 148 pg·min/ml; U = 15, p< 0.05), no difference in the CLON-induced inhibition of ACTH secretion was found between schizophrenie patients and controls (Figs. Ib and 2b) . No relationship between CLON-induced GH and ACTH responses was found.
Cortisol
No difTerence in the CLON-induced inhibition of cortisol secretion and in the total cortisol secretion during CLO N stimulation was found between schizophrenie patients and healthy subjects. When the relationship between ACTH and cortisol secretion during CLON stimulation was determined in all subjects, a positive correlation emerged which ws significant at the trend level (rs = 0.40, P < 0.1). No correlation between GH and cortisol responses to CLON could be demonstrated.
Discussion
Although the role of alpha-adrenergie receptors in the neuroregulation of GH relase is still a matter ofcontroversy (Lesch et aI. 1988), animal and human research suggests that the secretion of GH stimulated by the alpha2-adrenoceptor agonist CLON may a transient reduetion in symptoms with concurrent decrease of plasma norepinephrine and MHPG concentrations following CLON. Thus, although the pathophysiologieal significance of dysregulated noradrenergic funetion conceming state or trait dependency may vary between major depression and paranoid schizophrenia, some aspeets of noradrenergic dysregulation, both in relation to receptor binding and neuroendocrine responses to alpha2-adrenergic agonists, seem to be common in both disorder. Therefore, we conclude that disturbances in noradrenergic funetion and, specifically, the attenuated GH response to CLON max simply represent a nonspecific change secondary to acute or chronic stress, rather than a marker of any psychiatrie disorder. provide an indireet index of central alpha-adrenoceptor funetion. A blunted GH response to CLON has been consistently found in patients with major depression, but not in patients with secondary depression and dysthymic disorder (Matusseket al. 1980) . In contrast to this previous study, our finding suggests that paranoid schizophrenie and depressed patients demonstrate a similar blunted GH response to CLON whieh is consistent with an emerging body of evidence suggesting a partial overlap in neurobiology of schizophrenia and depression. A1though the two disorders are different in relation to hypothalamic-pituitary-adrenal axis dysregulation as indicated by incresed ACTH but normal cortisol secretion in the schizophrenie patients (Lesch et al. 1988) , recent attention has focused on the hypothesis that disturbances in noradrenergie funetion may be related to both disorders. In line with this perspective are the current findings of blunted GH responses to panie disorder, presumably refleeting distorted alpha-adrenergic neurotransmission as weil ( Uhdeet al. 1986 ). Anxiety and situational stress present during the test procedure, partieularly if they relate to the delusional system, may contribute to alphaadrenoceptor-related neuroendocrine dysregulation. Moreover, both schizophrenie and panic disorder patients experience
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